AI assistant
Sending…
Axogen, Inc. — Director's Dealing 2018
Jun 12, 2018
32414_dirs_2018-06-12_a0cf43c9-8313-46bd-ba12-43232b93175f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-09-08
Reporting Person: Rudelius Robert James (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-08 | Common Stock | M | 12000 | $2.75 | Acquired | 35273 | Direct |
| 2018-06-08 | Common Stock | F | 682 | $48.40 | Disposed | 34591 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-08 | Director Stock Option (right to purchase) | $2.75 | M | 12000 | Disposed | 2018-10-10 | Common Stock (12000) | Direct |
Footnotes
F1: This Form is being filed to report the exercise of a stock option for a total of 12,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,318 shares of common stock.
More from Axogen, Inc.
Major Shareholding Notification
2026
May 7
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Interim / Quarterly Report
2026
Apr 28
Earnings Release
2026
Apr 28
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3